JP2015523321A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015523321A5 JP2015523321A5 JP2015510368A JP2015510368A JP2015523321A5 JP 2015523321 A5 JP2015523321 A5 JP 2015523321A5 JP 2015510368 A JP2015510368 A JP 2015510368A JP 2015510368 A JP2015510368 A JP 2015510368A JP 2015523321 A5 JP2015523321 A5 JP 2015523321A5
- Authority
- JP
- Japan
- Prior art keywords
- effective amount
- use according
- mammal
- medicament
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000124008 Mammalia Species 0.000 claims 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 6
- 230000037396 body weight Effects 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 235000013312 flour Nutrition 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 235000012000 cholesterol Nutrition 0.000 claims 3
- 210000000936 intestine Anatomy 0.000 claims 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 241000606124 Bacteroides fragilis Species 0.000 claims 1
- 241000193403 Clostridium Species 0.000 claims 1
- 208000032928 Dyslipidaemia Diseases 0.000 claims 1
- 241000588921 Enterobacteriaceae Species 0.000 claims 1
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- 230000007413 intestinal health Effects 0.000 claims 1
- 208000006443 lactic acidosis Diseases 0.000 claims 1
- 230000037356 lipid metabolism Effects 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 230000004580 weight loss Effects 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261640622P | 2012-04-30 | 2012-04-30 | |
| US61/640,622 | 2012-04-30 | ||
| US201261691515P | 2012-08-21 | 2012-08-21 | |
| US61/691,515 | 2012-08-21 | ||
| US201361798992P | 2013-03-15 | 2013-03-15 | |
| US61/798,992 | 2013-03-15 | ||
| PCT/US2013/038696 WO2013165921A2 (en) | 2012-04-30 | 2013-04-29 | Therapeutic use of chardonnay seed products |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015523321A JP2015523321A (ja) | 2015-08-13 |
| JP2015523321A5 true JP2015523321A5 (enExample) | 2016-06-23 |
| JP6562837B2 JP6562837B2 (ja) | 2019-08-21 |
Family
ID=48430944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015510368A Active JP6562837B2 (ja) | 2012-04-30 | 2013-04-29 | シャルドネ種子製品の治療上の使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US10105409B2 (enExample) |
| EP (1) | EP2844266B1 (enExample) |
| JP (1) | JP6562837B2 (enExample) |
| KR (1) | KR102149348B1 (enExample) |
| CN (2) | CN104519895B (enExample) |
| AU (1) | AU2013256577B2 (enExample) |
| BR (1) | BR112014026926B1 (enExample) |
| CA (1) | CA2871265C (enExample) |
| EA (1) | EA201491817A1 (enExample) |
| ES (1) | ES2990038T3 (enExample) |
| IL (1) | IL235349B (enExample) |
| IN (1) | IN2014DN09085A (enExample) |
| NZ (1) | NZ701607A (enExample) |
| WO (1) | WO2013165921A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104519895B (zh) | 2012-04-30 | 2019-06-11 | 索那麦提科有限责任公司 | 霞多丽种子产品的治疗用途 |
| CA2946558A1 (en) * | 2014-04-21 | 2015-10-29 | Sonomaceuticals, Llc | Therapeutic use of grape seed products for the treatment of joint pain and/or joint inflammation |
| US10709751B2 (en) | 2014-05-30 | 2020-07-14 | Shaklee Corporation | Chardonnay grape seed extract |
| TWI723952B (zh) | 2014-05-30 | 2021-04-11 | 美商嘉康利公司 | 夏多內葡萄籽萃取物 |
| KR20240059654A (ko) * | 2014-12-20 | 2024-05-07 | 소노마슈티컬스, 엘엘씨 | 비알콜성 지방간 질환용 및 다른 용도의 포도 생산물 |
| EP3461337A1 (en) | 2015-05-06 | 2019-04-03 | Snipr Technologies Limited | Altering microbial populations & modifying microbiota |
| ITUB20154797A1 (it) * | 2015-10-20 | 2016-01-20 | Francesco Donati | Insieme di polveri per l'estrazione di bevande, e metodo per la realizzazione di tale insieme |
| GB201609811D0 (en) | 2016-06-05 | 2016-07-20 | Snipr Technologies Ltd | Methods, cells, systems, arrays, RNA and kits |
| BR112018076609B1 (pt) * | 2016-12-15 | 2023-02-14 | Société des Produits Nestlé S.A. | Composição alimentícia para animais de estimação, seus usos, e métodos não terapêutico para modular a quantidade e para medição de uma alteração na quantidade de pelo menos uma dentre bifidobacterium, lactobacillus ou clostridium perfringens |
| JP6898674B2 (ja) * | 2017-06-02 | 2021-07-07 | グッドガット エッセ．エッレ． | ディスバイオシスの治療のために用いられるブドウ果皮 |
| KR102037897B1 (ko) * | 2017-12-26 | 2019-10-30 | 한양대학교 산학협력단 | 케피어 유래 유산균 및 포도씨 분말을 포함하는 비만의 예방 또는 치료용 조성물 |
| KR102037898B1 (ko) * | 2017-12-26 | 2019-10-30 | 한양대학교 산학협력단 | 케피어 유래 유산균 및 포도씨 분말을 포함하는 지방간의 예방 또는 치료용 조성물 |
| US10760075B2 (en) | 2018-04-30 | 2020-09-01 | Snipr Biome Aps | Treating and preventing microbial infections |
| US11851663B2 (en) | 2018-10-14 | 2023-12-26 | Snipr Biome Aps | Single-vector type I vectors |
| KR102217834B1 (ko) * | 2018-11-13 | 2021-02-19 | 한양대학교 산학협력단 | 케피어 유래 유산균의 사균체 및 포도씨 분말을 함유하는 비만의 예방 또는 치료용 조성물 |
| JP7279943B2 (ja) * | 2020-07-03 | 2023-05-23 | 株式会社エーゼット | ブドウ種子抽出物を含む更年期障害改善剤 |
| RU2747660C1 (ru) * | 2020-07-06 | 2021-05-11 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный технологический университет" (ФГБОУ ВО "КубГТУ") | Способ персонификации питания с учетом генетически детерминированных факторов |
| JP2023545515A (ja) * | 2020-10-16 | 2023-10-30 | ソノマシューティカルズ・エルエルシー | 農産物搾りかすを含む食品組成物とその製造方法 |
| GB202209518D0 (en) | 2022-06-29 | 2022-08-10 | Snipr Biome Aps | Treating & preventing E coli infections |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1951200A (en) * | 2000-02-28 | 2001-08-30 | Vo Hanh Nhu Thi | Seedless chardonnay |
| US20020192314A1 (en) * | 2001-03-06 | 2002-12-19 | Cho Suk H. | Dietary supplement compositions |
| KR100448447B1 (ko) * | 2002-12-17 | 2004-09-13 | 주식회사 엔바이오테크놀러지 | 알파 글루코시다제 저해활성을 갖는 포도씨 추출물을함유하는 조성물, 제조방법 및 이의 용도 |
| US20050129790A1 (en) * | 2003-11-17 | 2005-06-16 | Folts John D. | Polyphenol-containing stem and vine extracts and methods of use |
| US20060172012A1 (en) | 2005-01-28 | 2006-08-03 | Finley John W | Anti-inflammatory supplement compositions and regimens to reduce cardiovascular disease risks |
| CN101277616A (zh) * | 2005-09-28 | 2008-10-01 | 美露香株式会社 | γ-氨基丁酸含量提高的果实的制造方法 |
| CN100571537C (zh) * | 2006-11-07 | 2009-12-23 | 西北农林科技大学 | 一种葡萄籽超微粉胶囊的生产方法 |
| US20090082738A1 (en) | 2007-09-24 | 2009-03-26 | Vad Vijay B | Natural Anti-Inflammatory Agents for Reducing Pain |
| CN102612564B (zh) | 2009-04-10 | 2015-08-26 | 齐海燕 | 新的抗衰老试剂及其鉴别方法 |
| US20110217417A1 (en) * | 2009-05-04 | 2011-09-08 | Daniel Perlman | Phenolic antioxidant-supplemented infusion beverage |
| DE202009013228U1 (de) | 2009-09-30 | 2011-02-10 | Tavarlin Ag | Glutenfreie Nahrungsmittel |
| CN104519895B (zh) * | 2012-04-30 | 2019-06-11 | 索那麦提科有限责任公司 | 霞多丽种子产品的治疗用途 |
| CA2946558A1 (en) | 2014-04-21 | 2015-10-29 | Sonomaceuticals, Llc | Therapeutic use of grape seed products for the treatment of joint pain and/or joint inflammation |
-
2013
- 2013-04-29 CN CN201380026061.9A patent/CN104519895B/zh active Active
- 2013-04-29 CN CN201910426268.4A patent/CN110433230A/zh active Pending
- 2013-04-29 BR BR112014026926-2A patent/BR112014026926B1/pt active IP Right Grant
- 2013-04-29 US US14/398,093 patent/US10105409B2/en active Active
- 2013-04-29 KR KR1020147031337A patent/KR102149348B1/ko active Active
- 2013-04-29 ES ES13722639T patent/ES2990038T3/es active Active
- 2013-04-29 WO PCT/US2013/038696 patent/WO2013165921A2/en not_active Ceased
- 2013-04-29 CA CA2871265A patent/CA2871265C/en active Active
- 2013-04-29 EP EP13722639.5A patent/EP2844266B1/en active Active
- 2013-04-29 NZ NZ701607A patent/NZ701607A/en unknown
- 2013-04-29 JP JP2015510368A patent/JP6562837B2/ja active Active
- 2013-04-29 IN IN9085DEN2014 patent/IN2014DN09085A/en unknown
- 2013-04-29 AU AU2013256577A patent/AU2013256577B2/en active Active
- 2013-04-29 EA EA201491817A patent/EA201491817A1/ru unknown
-
2014
- 2014-10-27 IL IL235349A patent/IL235349B/en active IP Right Grant
-
2018
- 2018-09-28 US US16/145,595 patent/US10772924B2/en active Active
-
2020
- 2020-09-14 US US17/020,533 patent/US11723943B2/en active Active
-
2023
- 2023-06-22 US US18/339,310 patent/US20240024404A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015523321A5 (enExample) | ||
| NZ702169A (en) | The use of heat shock protein 90 (hsp90) modulators for the treatment of metabolic syndrome | |
| EA201401028A1 (ru) | Фармацевтическая композиция, содержащая эмпаглифлозин и лекарственное средство от ожирения | |
| EA033067B1 (ru) | Способ лечения метаболических расстройств у пациента, имеющего противопоказание к назначению бигуанидного соединения | |
| BR112014014262A2 (pt) | nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas. | |
| NZ612504A (en) | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents | |
| EA201490004A1 (ru) | Применение bifidobacterium lactis bl-04 для лечения заболеваний дыхательных путей | |
| MA38276A1 (fr) | Dérivés de l'exendine 4 pour l’utilisation dans le traitement des troubles du syndrome metabolique, y compris le diabete et l'obesite, ainsi que la reduction de l'apport alimentaire excessif. | |
| EA201390827A1 (ru) | Применение лаквинимода для уменьшения утомляемости, улучшения функционального состояния и улучшения качества жизни пациентов с рассеянным склерозом | |
| NZ601167A (en) | Treatment of cardiac conditions | |
| PH12013500892B1 (en) | Composition for use in the prevention and\or treatment of skin conditions and skin diseases | |
| MY187609A (en) | Human milk oligosaccharides to ameliorate symptoms of stress | |
| WO2015092020A3 (en) | Diagnostic, prognostic and therapeutic uses of long noncoding rnas for heart disease and regenerative medicine | |
| UA99953C2 (uk) | Лікування релаксином задишки, асоційованої з гострою серцевою недостатністю | |
| MY175997A (en) | Antl-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig protein scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition | |
| NZ757815A (en) | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity | |
| JP2016537410A5 (enExample) | ||
| WO2010151755A3 (en) | TREATMENT OF INFLAMMATORY DISEASES USING miR-124 | |
| JP2013541583A5 (enExample) | ||
| WO2012142413A3 (en) | Nitrite compositions and uses thereof | |
| JP2012516348A5 (enExample) | ||
| AU2012334804A8 (en) | Modulators of C3a receptors | |
| JP2013523758A5 (enExample) | ||
| GEP20156386B (en) | New crystal form vii of agomelatine, preparation method and usage thereof, and pharmaceutical compositions containing thereof | |
| JP2017061488A5 (enExample) |